Cargando…
Diagnostic Performance of (99m)Tc-Methoxy-Isobuty-Isonitrile (MIBI) for Risk Stratification of Hypofunctioning Thyroid Nodules: A European Multicenter Study
(99m)Tc-MIBI (MIBI) imaging is able to exclude malignancy of hypofunctioning thyroid nodules (TNs) with high probability but false positive results are frequent due to low specificity. Therefore, pre-test selection of appropriate TNs is crucial. For image evaluation visual and semiquantitative metho...
Autores principales: | Schenke, Simone Agnes, Campennì, Alfredo, Tuncel, Murat, Bottoni, Gianluca, Sager, Sait, Bogovic Crncic, Tatjana, Rozic, Damir, Görges, Rainer, Özcan, Pinar Pelin, Groener, Daniel, Hautzel, Hubertus, Klett, Rigobert, Kreissl, Michael Christoph, Giovanella, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221758/ https://www.ncbi.nlm.nih.gov/pubmed/35741167 http://dx.doi.org/10.3390/diagnostics12061358 |
Ejemplares similares
-
Diagnostic Performance of Different Thyroid Imaging Reporting and Data Systems (Kwak-TIRADS, EU-TIRADS and ACR TI-RADS) for Risk Stratification of Small Thyroid Nodules (≤10 mm)
por: Schenke, Simone, et al.
Publicado: (2020) -
Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer
por: Giovanella, Luca, et al.
Publicado: (2023) -
Molecular imaging with (99m)Tc-MIBI and molecular testing for mutations in differentiating benign from malignant follicular neoplasm: a prospective comparison
por: Giovanella, L., et al.
Publicado: (2015) -
Differentiating malignant from benign thyroid nodules with indeterminate cytology by (99m)Tc-MIBI scan: a new quantitative method for improving diagnostic accuracy
por: Campennì, A., et al.
Publicado: (2017) -
Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer
por: Petranović Ovčariček, Petra, et al.
Publicado: (2023)